McGowan Institute for Regenerative Medicine faculty member Tao Cheng, M.D., co-leader of the Cancer Stem Cell Program at the University of Pittsburgh Cancer Institute, and associate professor, University of Pittsburgh School of Medicine, biochemistry and molecular genetics program, was selected to receive the Scholar Award from the Leukemia and Lymphoma Society. The award consists of $550,000 over 5 years and is given to highly qualified investigators who have shown a capacity for independent, sustained original investigation in the field of leukemia, lymphoma, and myeloma.
Dr. Cheng is presently an active member of the American Society of Hematology, the American Society of Gene Therapy, International Society of Experimental Hematology, the International Society for Stem Cell Research, and the American Association for Cancer Research. Dr. Cheng is also a member of the NIH study sections, and a reviewer for quite a few Journals including Science, Nature Medicine and Nature Methods, PNAS, Blood Stem Cells, Oncogene, and the Journal for Leukocyte Biology. He is also an Editorial Board Member for Experimental Hematology. Dr. Cheng is involved in several research projects including:
- Cell cycle control of stem cell populations.
- Self-renewal mechanisms for normal and leukemia stem cells.
- Factors determining the efficacy of stem cell transplantation.
The Leukemia & Lymphoma Society is the world's largest voluntary health organization dedicated to funding blood cancer research, education, and patient services. The Society's mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. Since its founding in 1949, the Society has invested more than $550.8 million for research specifically targeting blood cancers.
Congratulations, Dr. Cheng, for this recognition of your significant scientific achievements and exceptional leadership.
Illustration: McGowan Institute for Regenerative Medicine
Read more…
UPMC/University of Pittsburgh Schools of the Health Sciences Media Relations (03/10/08)